Confirmatory Phase 3 Trial of MDMA Therapy for PTSD is “Successful”,...

Algernon Pharmaceuticals Forms Private Subsidiary to Advance Company’s Psychedelic DMT Stroke...

PT380 – Microdosing, Talking to Physicians About Psychedelics, and Nurses as...

Psychedelics Weekly – Psilocybin and Stress Response, the Minnesota Medical Association...

Clearmind Medicine Announces Shareholders Meeting Results

Israel-Based Clearmind Medicine Announces First Clinical Center to Join Its Clinical...

PT379 – Intergenerational Trauma, Late-Stage Capitalism, and the Urban Indigenous Collective

Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures...

Revive Therapeutics Announces Submission of Type C Meeting Request to FDA...

Psychedelics Weekly – Prop 122 and Data Privacy, Ending the Crack/Cocaine...

Load more